BBIO - BridgeBio Pharma, Inc.
IEX Last Trade
28.39
0.030 0.106%
Share volume: 32,404
Last Updated: Thu 26 Dec 2024 08:30:14 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$28.36
0.03
0.11%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-22 | 2024-05-02 | 2024-08-01 | |
| Total revenue | 338.000 K | 1.870 M | 1.826 M | 1.641 M | 4.091 M | 1.745 M | 211.120 M | 2.168 M | |
| Cost of revenue | 739.000 K | 647.000 K | 651.000 K | 599.000 K | 598.000 K | 598.000 K | 598.000 K | 598.000 K | |
| Gross profit | -401.000 K | 1.223 M | 1.175 M | 1.042 M | 3.493 M | 1.147 M | 210.522 M | 1.570 M | |
| 404.99% | -3.92% | -11.32% | 235.22% | -67.16% | 18,254.14% | -99.25% | |||
| Operating expenses | 123.699 M | 122.764 M | 123.969 M | 143.610 M | 160.913 M | 177.809 M | 206.779 M | 174.218 M | |
| Selling general and admin | 31.188 M | 31.862 M | 31.108 M | 36.122 M | 35.777 M | 47.583 M | 65.807 M | 59.523 M | |
| Research and development | 92.511 M | 90.902 M | 92.861 M | 107.488 M | 125.136 M | 130.226 M | 140.972 M | 114.695 M | |
| Total expenses | 124.438 M | 123.411 M | 124.620 M | 144.209 M | 161.511 M | 178.407 M | 207.377 M | 182.741 M | |
| -0.83% | 0.98% | 15.72% | 12.00% | 10.46% | 16.24% | -11.88% | |||
| Operating income | -124.100 M | -121.541 M | -122.794 M | -142.568 M | -157.420 M | -176.662 M | 3.743 M | -180.573 M | |
| Ebit | -124.100 M | -121.541 M | -122.794 M | -142.568 M | -157.420 M | -176.662 M | 3.743 M | -180.573 M | |
| Pretax income | -140.193 M | -140.570 M | -142.732 M | -160.703 M | -179.488 M | -170.328 M | -36.160 M | -75.544 M | |
| 0.27% | 1.54% | 12.59% | 11.69% | -5.10% | -78.77% | 108.92% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -137.339 M | -137.591 M | -140.156 M | -157.899 M | -176.999 M | -168.148 M | -35.216 M | -73.456 M | |
| -0.18% | -1.86% | -12.66% | -12.10% | 5.00% | 79.06% | -108.59% | |||
| Net income | -137.339 M | -137.591 M | -140.156 M | -157.899 M | -176.999 M | -168.148 M | -35.216 M | -73.456 M | |
| -0.18% | -1.86% | -12.66% | -12.10% | 5.00% | 79.06% | -108.59% |